Our Focus Areas

With more than five decades of experience in the US generics market, we’ve always put patients and healthcare providers at the center of our efforts—delivering cost-effective generic pharmaceuticals that meet diverse needs, without compromising on quality.  

Our portfolio of ~80 therapeutically equivalent ANDA-based product families includes oral solids, liquids, powders, sprays, and transdermal patches that serve a range of conditions.  

We’re also one of the few vertically integrated generics manufacturers—from API to finished dose—backed by four API sites, including three in the US.

With a global reach of 350 customers across 70 countries, we drive the standard for quality, reliability, and technical expertise in premium API and excipients supply.  

We manufacture a wide range of APIs across our highly regulated supply chain in the US and India. Known for reliable, high-quality production, we deliver secure, customer-focused service worldwide. Our integrated supply chain includes our St. Louis, MO facility—the largest API plant in the US—while our Raleigh, NC, and Greenville, IL sites are the only producers of bulk acetaminophen/paracetamol APIs in the Western Hemisphere. 

We partner with hospitals and healthcare systems to reduce complexity through life-enhancing solutions, innovating together to add value where it matters—from manufacturing to treatment—so that healthcare providers can focus on patient care. 

Our sterile product portfolio spans various therapeutic categories and includes both branded and generic injectables. 

Our ready-to-use (RTU) products, available through our TruDelivery® portfolio, streamline hospital operations by eliminating the need for preparation or transfer before patient administration. This can help save time, minimize potential medication errors, and enhance workflow efficiency—supporting impactful care in hospitals, clinics, and home health and long-term care systems.